Drug Resistance Patterns of Tuberculosis in Cameroon
Author Information
Author(s): Assam-Assam Jean-Paul, Penlap Veronique B, Cho-Ngwa Fidelis, Tedom Jean-Claude, Ane-Anyangwe Irene, Titanji Vincent P
Primary Institution: University of Buea, Cameroon; University of Yaoundé I, Cameroon
Hypothesis
What are the current levels of drug resistance in Mycobacterium tuberculosis complex strains in Cameroon?
Conclusion
Resistance to first line anti-TB drugs has significantly declined in Cameroon, but remains high overall.
Supporting Evidence
- 20.37% of suspected patients tested positive for TB.
- Resistance to at least one drug was found in 10.73% of cases.
- MDR-TB was observed only in the West region at a rate of 6.67%.
- No resistance was recorded for ethambutol.
Takeaway
The study looked at how many tuberculosis germs in Cameroon are resistant to medicines, and found that while some resistance has gone down, it's still a big problem.
Methodology
The study involved testing sputum samples from suspected TB patients for drug resistance using standard microbiological methods.
Potential Biases
Potential bias in patient selection and reporting of drug resistance.
Limitations
The study may not represent all regions of Cameroon and relies on data from specific hospitals.
Participant Demographics
The study included 756 suspected TB patients, with 64.93% men and 35.07% women, and 20.77% were HIV positive.
Statistical Information
P-Value
p < 0.05 for West; p < 0.01 for Centre
Statistical Significance
p < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website